Effects of centrally administered opioid agonists on macrophage nitric oxide production and splenic lymphocyte proliferation

Advances in Experimental Medicine and Biology

Volumn 402, Issue , 1996, Pages 81-88

  Schneider, Gabrielle M ^a   Lysle, Donald T ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; N(G) METHYL DEXTRO ARGININE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; OPIATE AGONIST; TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; TOXIC SHOCK SYNDROME;

ANIMALIA;

EID: 0029818533     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0407-4_12     Document Type: Conference Paper

References (36)

1. Hibbs, J.B., Tiantor, R.R., & Vavrin, Z. (1987). Macrophage cytotoxicity: Role for L-arginine deaminase and iminonitrogenoxidation of nitrite. Science, 235, 473-476.
2. Iyengar, R., Stuehr, D.J., & Marletta, M.A. (1987). Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc. Natl. Acad. Sci. USA 84, 6369-6373.
3. Marietta, M. A., Yoon, P.S., Iyengar, R., Leaf, C.D., & Wishnok, J.S. (1988). Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochem., 27, 8706-8711.
4. Goretski, J., & Hollocher, T.C. (1988). Trapping of nitric oxide produced during denitrification by extracellular hemoglobin. J. Biol. Chem., 263, 2316-2323.
5. Pellat, C., Henry, Y., & Drapier, J.C. (1990). IFN-γ-activated macrophages: detection by electron paramagnetic resonance of complexes between L-arginine-derived nitric oxide and non-heme iron proteins. Biochem. Biophys. Res. Comm., 166, 119-125.
6. 15N]nitrate in biological fluids. Anal. Biochem., 126, 131-136.
7. Nathan, C. (1992). Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 3051-3064.
8. Fecho, K., Maslonek, K.A., Coussons-Read, M.E., Dykstra, L.A., & Lysle, D.T. (1994). Macrophage-derived nitric oxide is involved in the depressed Con A-responsiveness of splenic lymphocytes from rats administered morphine in-vivo. Journal of Immunology, 152, 5845-5852.
9. Fecho, K., Maslonek, K.A., Dykstra, L.A., & Lysle, D.T. (1995). Mechanisms whereby macrophage-derived nitric oxide is involved in morphine-induced suppression of splenic lymphocyte proliferation. Journal of Pharmacology and Experimental Therapeutics, 272, 477-483.
10. Wybran, J., Appelboom, T. Famey, J.P. & Govaerts, A. (1979). Suggestive evidence for receptors for morphine and methionine enkephalin on normal human blood T-lymphocytes. J. Immunol., 123, 1068-1070.
11. Eisenstein, T.K., Taub, D.D., Adler, M.W. and Rogers, T.J. (1991). The effect of morphine and DAGO on the proliferative response of murine splenocytes. Adv. Exp. Med. Biol., 288, 203-209.
12. Bayer, B.M., Gastonguay, M.R. and Hernandez, M.C. (1992). Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility. Immunopharmacology. 23, 117-124.
13. Peterson, P.K., Sharp, B., Gekker, G., & Keane, W.F. (1987). Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. J Immunology, 138, 3907-3912.
14. Ader, R., Felten, D. & Cohen, N. (1990). Interactions between the brain and the immune system. Annu. Rev. Pharmacol. Toxicol., 30, 561-602.
15. Felten, D.L., Felten, S.Y., Bellinger, D.L., Carlson, S.L., Ackerman, K.D., Madden, K.S., Olschowki, J.A., & Livnat, S., (1987). Noradrenergic sympathetic neural interactions with the immune system: Structure and function. Immunological Reviews, 100, 225-260.
16. Shavit, Y., DePaulis, A., Martin, F. C., Terman, G. W., Pechnick, R. N., Zane, C. J., Gale, R. P. and Liebeskind, J. C. (1986). Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc. Nail. Acad. Sci, 83, 7114-7117.
17. Weber, R.J. & Pert, A. (1989). The periaqueductal grey matter mediates opiate-induced immunosuppression. Science, 245, 188-190.
18. Hernandez, M.C., Flores. L.H., Bayer, B.M. (1993). Immunosuppression by morphine is mediated by central pathways. J. Pharmacol. Exp. Ther., 267, 1336-1341.
19. Lysle, D.T., Hoffman, K.E., & Dykstra, L.A. Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status. Journal of Pharmacology and Experimental Therapeutics, in press.
20. Fecho, K., Maslonek, K.A., Dykstra, L.A. and Lysle, D.T. Assessment of the involvement of the central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther., in press.
21. Jaffe, J.H. and Martin, W.R. (1990). Opioid analgesics and antagonists. In A.G. Gilman, T.W. Rall, A.S. Nies, & P. Taylor (Eds.) Goodman and Gilman's The Pharmacological Basis of Therapeutics. pp. 485-521, Pergamon Press: New York.
22. Goldstein, A. (1987). Binding selectivity profiles for ligands of multiple receptor types: Focus on opioid receptors. Trends in Pharmacol Sci, 8, 456-466.
23. Marrack, P. & Kappler, J. (1990). The staphylococcal enterotoxins and their relatives. Science, 248, 705-711.
24. White, H., Herman, A., Pullen, A.M., Kubo, R., Kappler, J.W., & Marrack, P. (1989). The Vß specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice. Cell, 56, 27-35.
25. Leonard, B.A.B., Lee, P.K., Jenkins, M.K., & Schlicvert, P.M. (1991). Cell and receptor requirement for streptococcal pyrogenic exotoxin T-cell mitogenicity. Infection & Immunity, 59, 1210.
26. Green, S.J., Meltzer, M.S. Hibbs, J.B, & Nacy, C.A. (1990). Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. Journal of Immunology, 144, 278-283.
27. James, S.L. & Glaven, J. (1989). Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. Journal of Immunology, 143, 4208-4212.
28. Vincendeau, P., Daulouede, S., Veyret, B., Darde, M.L., Bouteille, B., & Lemesre, J.L. (1992). Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei. Experimental Parasitology, 75, 353-360.
29. MacMicking, J.D., Nathan, C., Hom, G. Chartrain, N., Fletcher, D.S., Trumbauer, M., Stevens, K., Xie, Q.W., Sokol, K., Hutchinson, N. Chen, H., & Mudgett, J.S. (1995). Altered responses to baterial infection and endotoxic shock in mice lacking inducible nitric oxide syntase. Cell, 81, 641-650.
30. Wei, X.Q., Charles, I.G., Smith, A., Ure, J., Feng, G.J., Huang, F.P., Xu, D., Muller, W., Mocado, S., Liew, F.Y. (1995). Altered immune responses in mice lacking inducible nitric oxide synthase. Nature, 375, 408-411.
31. G-monomethyl-Larginine. Journal of Experimental Medicine, 179, 651-660.
32. Al-Ramadi, B.K., Meissler, J.J., Huang, D., Eisenstein, T.K. (1992). Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. European Journal of Immunology, 22, 2249-2254.
33. Eisenstein, T.K., Huang, D. Meissler, J.J., & Al-Ramadi, B. (1994). Macrophage nitric oxide mediates immunosuppression in infectious inflammation. Immunobiol., 191, 493-502.
34. Albina, J.E. & Henry, W.L. (1991). Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway. Journal of Surgical Research, 50, 403-409.
35. Fu, Y. & Blankenhorn, E.P. (1992). Nitric oxide-induced anti-mitogenic effects in high and low responder strains. Journal of Immunology, 148, 2217-2222.
36. Pascual, D.W., Pascual, V.H., Bost, K.L., McGhee J.R., & Oparil, S. (1992). Nitric oxide mediates immune dysfunction in the spontaneously hypertensive rat. Hypertension, 21, 185-194.